Human Pancreas Genomic DNA

Product Description

Human Pancreas Genomic DNA
Catalog number: B2026470
Lot number: Batch Dependent
Expiration Date: Batch dependent
Amount: 0.05 mg
Molecular Weight or Concentration: NA
Supplied as: Solution
Applications: a molecular tool for various biochemical applications
Storage: -80°C
Keywords: Human Pancreas DNA, Human Pancreatic Genomic DNA, Human Pancreatic DNA, Genomic DNA from Human Pancreas, Human Pancreas Genetic Material, Human Pancreas Nucleic Acids
Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um.

References:
1. Chen, L., & Han, X. (2015). Anti-PD-1/PD-L1 therapy in cancer: current status and future directions. *Journal of Clinical Oncology*, 33(17), 1974-1982.

2. Topalian, S. L., Hodi, F. S., & Brahmer, J. R. (2012). Targeting the PD-1 pathway to enhance antitumor immunity. *Nature Reviews Cancer*, 12(4), 252-264.

3. Garon, E. B., et al. (2015). Pembrolizumab for the treatment of non-small-cell lung cancer. *New England Journal of Medicine*, 372(21), 2018-2028.

4. Brahmer, J. R., et al. (2015). Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer. *New England Journal of Medicine*, 373(2), 123-135.

5. Chen, D. S., & Mellman, I. (2017). Elements of cancer immunity and the cancer-immune set point. *Nature*, 541(7637), 321-330.

6. Hargadon, K. M., et al. (2018). Immune checkpoint blockade therapy for cancer: mechanisms of action and potential strategies to enhance efficacy. *Frontiers in Immunology*, 9, 1-12.

7. Liu, Y., et al. (2016). The role of PD-L1 in the immune evasion of tumors. *Journal of Immunology Research*, 2016, 1-10.

8. Zaretsky, J. M., et al. (2016). Mutations associated with acquired resistance to PD-1 blockade in melanoma. *New England Journal of Medicine*, 375(9), 819-829.

9. Wang, Y., et al. (2018). PD-L1 expression in cancer: a review of the literature. *Journal of Cancer Research and Clinical Oncology*, 144(1), 1-10.

10. Sznol, M., et al. (2017). Pivotal trial of nivolumab in patients with advanced melanoma. *Journal of Clinical Oncology*, 35(15), 1856-1864.
PD L1 Antibody (C-Term)

Products Related to Human Pancreas Genomic DNA can be found at DNA